|
|
|
Volumn 28, Issue 4, 1996, Pages 2187-2188
|
|
Safety and tolerability of sandimmun neoral vs sandimmun in de novo renal transplant patients after 24 months' treatment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
STEROID;
CLINICAL TRIAL;
CONFERENCE PAPER;
CREATININE CLEARANCE;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG FORMULATION;
DRUG INDUCED DISEASE;
DRUG SAFETY;
EMULSION;
FEMALE;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
AZATHIOPRINE;
BLOOD PRESSURE;
CREATININE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FUNCTION TESTS;
KIDNEY TRANSPLANTATION;
STEROIDS;
TIME FACTORS;
|
|
EID: 0029833939
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
